Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ROBIN MEDICAL INC
- Proposal award date
- 2016-09-05
- Contract end date
- 2019-08-31
- UEI
- S38NM2MSMM14
- Solicitation number
- PAR14-088
- Topic code
- NCI
Research abstract
Project Summary Abstract
Radiofrequency ablation RFA is a minimally invasive method used to treat solid tumors commonly primary
liver cancers and metastases which are accessible percutaneously via a sharp needle Imaging guidance
typically by ultrasound or CT is required for probe placement but these methods are incapable of monitoring
the progress of the procedure Additional imaging sessions are required to initially locate the tumor and to
assess the effectiveness of the therapy
The overall goal of this project is to translate into clinical practice a novel MRI mediated RFA therapy In this
method RF energy is provided and controlled by the MRI scanner eliminating the need for an external RF
generator and a grounding pad The MRI scanner additionally offers superior soft tissue contrast for tumor
localization and real time guidance of RF probe placement using a commercial gradient based navigation
system Additionally monitoring of tissue rather than probe temperature is possible during the procedure
permitting immediate assessment of the success of the ablation Eliminating the grounding pad reduces the
possibility of patient burns and therefore increases patient safety
An initial R exploratory grant funded basic discovery research into this technology comprising theoretic
scientific and technical development of MRI mediated RFA resulting in the demonstration of proof of principle
in phantoms tissue specimens animal cadavers and live animals The purpose of the current project is to
translate these basic findings into a safe and practical system for clinical use and to conduct a human clinical
pilot project to assess if a full clinical trial is warranted
Specific aims include
Develop integrated biopsy and RFA probes for MRI mediated RF ablation
Optimize the performance of MRI mediated RFA in phantom study
Optimize performance and safety of MRI mediated biopsy and RFA in an animal study
Conduct the required regulatory activities needed to enable human study of the system
Perform pilot study in humans with liver cancer to be treated by chemotherapy
The long term goal of the research is to develop a time efficient cost effective minimally invasive one stop
shop treatment for solid tumors treatable by thermal ablation If successful it will provide a powerful diagnostic
and therapeutic tool that can be used on any MRI scanner with low cost disposable devices and without the
need to add major external apparatus This is expected to facilitate the use of MRI guided RFA to treat a wide
range of tumors as a replacement for more invasive and more costly surgical management contributing to the
PHS mission of improving health care delivery while reducing cost and patient discomfort Project Narrative
The goal of this research is to translate into clinical practice a novel minimally invasive therapy system to treat
cancer and other tumors The system provides superior control and monitoring of the treatment while it is in
progress This is expected to improve the probability of successful treatment and improved patients outcome It
is expected that expanded use of this type of treatment will lead to a reduction in more invasive and costly
surgical management which in turn will reduce cost and patient discomfort while speeding recovery
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
24 SBIR/STTR records share this UEI (1998–2020). Reported award amounts total $18,932,366. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards